Benefit agent delivery composition with a low content of shell particles

US9896649B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9896649-B2
Application numberUS-201414547896-A
CountryUS
Kind codeB2
Filing dateNov 19, 2014
Priority dateJul 30, 2008
Publication dateFeb 20, 2018
Grant dateFeb 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to encapsulated benefit agents, compositions comprising such encapsulated benefit agents and processes for making and using compositions comprising such encapsulated benefit agents that do not require or require a reduced amount of scavenger materials. Such encapsulated benefit agents, compositions comprising such encapsulated benefit agents are processed such that no or lower levels of scavenger materials are required.

First claim

Opening claim text (preview).

What is claimed is: 1. A benefit agent delivery composition comprising, based on total benefit agent delivery composition weight; a.) from about 2% to about 95% of an encapsulated benefit agent; b.) from about 1% to about 30% polymeric shell particles, wherein the polymeric shell particles comprise formaldehyde scavenged from the benefit agent delivery composition and act as formaldehyde reservoirs to decrease a level of formaldehyde in the benefit agent delivery composition; and c.) the balance of said benefit agent delivery composition being one or more processing aids and carriers. 2. The benefit agent delivery composition of claim 1 , wherein said encapsulated benefit agent comprises a benefit agent selected from the group consisting of perfumes; brighteners; insect repellants; silicones; waxes; flavors; vitamins; fabric softening agents; skin care agents; enzymes; anti-bacterial agents; bleaches; and mixtures thereof. 3. The benefit agent delivery composition of claim 1 , wherein said formaldehyde scavenged from the benefit agent delivery composition is generated by a reaction of amino resins. 4. The benefit agent delivery composition of claim 1 , wherein the encapsulated benefit agent comprises a perfume raw material selected from the group consisting of Quadrant I, II, III and IV perfume raw materials and mixtures thereof. 5. The benefit agent delivery composition of claim 1 , wherein said one or more processing aids are selected from the group consisting of water, aggregate inhibiting materials, soil suspending polymers, and mixtures thereof. 6. The benefit agent delivery composition of claim 1 , wherein said one or more carriers is selected from the group consisting of polar solvents, and mixtures thereof. 7. The benefit agent delivery composition of claim 6 , wherein: a. said perfume comprises a perfume raw material selected from the group consisting of Quadrant I, II, III and IV perfume raw materials and mixtures thereof; b. said one or more processing aids are selected from the group consisting of water, aggregate inhibiting materials such as divalent salts, soil suspending polymers and mixtures thereof; and c. said one or more carriers is selected from the group consisting of water, ethylene glycol, propylene glycol, polyethylene glycol, glycerol, nonpolar solvents, and mixtures thereof. 8. A benefit agent delivery composition made by a process comprising the process of separating polymeric shell particles from encapsulated benefit agents in a benefit agent delivery composition under conditions sufficient to reduce the percentage of said polymeric shell particles in said benefit agent delivery composition by at least 20%, said separating step being selected from one or more of centrifuging, filtering, solvent exchanging, flash evaporating, decanting, flotation separating, spray drying, reactive adsorbing, reactive absorbing, and electrophoreticly separating, wherein the benefit delivery composition comprises one or more encapsulated benefit agents in the absence of added formaldehyde scavenger materials and greater than 01%′ polymeric shell particles, said polymeric shell particles comprising a residual by-product of an encapsulation process; and wherein the polymeric shell particles act as formaldehyde reservoirs to decrease a level of formaldehyde in the benefit agent delivery composition. 9. The benefit agent delivery composition of claim 1 , wherein said encapsulated benefit agent comprises a sufficient amount of benefit agent to provide, based on total benefit delivery composition weight, from about 1% to about 85% benefit agent. 10. The benefit agent delivery composition of claim 2 , wherein the skin care agent comprises paraffins. 11. The benefit agent delivery composition of claim 3 , wherein the amino resin comprises one or both of a melamine resin and a urea resin. 12. The benefit agent delivery composition of claim 5 , wherein the aggregate inhibiting materials comprise divalent salts. 13. The benefit agent delivery composition of claim 6 , wherein the polar solvents are selected from the group consisting of water, ethylene glycol, propylene glycol, polyethylene glycol, glycerol, and mixtures thereof. 14. The benefit agent delivery composition of claim 6 wherein the nonpolar solvents are selected from the group consisting of mineral oil, perfume raw materials, silicone oils, hydrocarbon paraffin oils, and mixtures thereof. 15. The benefit agent delivery composition of claim 7 wherein the nonpolar solvents are selected from the group consisting of mineral oil, perfume raw materials, silicone oils, hydrocarbon paraffin oils, and mixtures thereof. 16. The benefit agent delivery composition of claim 7 wherein the aggregate inhibiting materials comprise divalent salts. 17. The benefit agent delivery composition of claim 1 wherein said encapsulated benefit agent comprises a sufficient amount of benefit agent to provide, based on total benefit delivery composition weight, from about 1% to about 20% benefit agent.

Assignees

Inventors

Classifications

  • Solutions {(composition of solutions A61K47/00)} · CPC title

  • obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds · CPC title

  • Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

  • A61K8/11Primary

    Encapsulated compositions · CPC title

  • Formulations or additives for perfume preparations (essential oils or perfumes per se C11B9/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9896649B2 cover?
The present application relates to encapsulated benefit agents, compositions comprising such encapsulated benefit agents and processes for making and using compositions comprising such encapsulated benefit agents that do not require or require a reduced amount of scavenger materials. Such encapsulated benefit agents, compositions comprising such encapsulated benefit agents are processed such th…
Who is the assignee on this patent?
Appvion Inc, Encapsys Llc
What technology area does this patent fall under?
Primary CPC classification A61K8/11. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).